Long-term efficacy of fremanezumab in chronic and episodic migraine patients who failed at least one prior migraine preventive medication: results of a 1-year study

被引：0
|
作者：
Winner, Paul K. [1 ]
Freeman, Marshall C. [2 ]
Cohen, Joshua M. [3 ]
Yang, Ronghua [3 ]
Ning, Xiaoping [3 ]
Blaiss, Cory [3 ]
机构：
[1] Premiere Res Inst, W Palm Beach, FL USA
[2] Headache Wellness Ctr, Greensboro, NC USA
[3] Teva Pharmaceut, Frazer, PA USA
来源：
CEPHALALGIA | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-DP-028
引用
收藏
页码：36 / 37
页数：2
相关论文
共 50 条
  • [1] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, P. K.
    Freeman, M. C.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 118 - 119
  • [2] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Ortega, Mario
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S168 - S169
  • [3] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Episodic Migraine Who Have Failed At least One Prior Preventive Migraine Medication: Results of a 1-Year Study
    Brandes, J.
    Smith, T. R.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 119 - 120
  • [4] Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with episodic migraine who have failed at least one prior preventive migraine medication: results of a 1-year study
    Brandes, Jan L.
    Smith, Timothy R.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Carr, Karen
    [J]. CEPHALALGIA, 2019, 39 : 233 - 233
  • [5] Long-Term Efficacy of Fremanezumab in Patients with Episodic Migraine and Chronic Migraine Who Failed at Least One Prior Migraine Preventive Medication: Results from 6-and 12-Month Studies
    Dougherty, Carrie
    Ning, Xiaoping
    Cohen, Joshua M.
    Yang, Ronghua
    Campos, Verena Ramirez
    Seminerio, Michael
    Silberstein, Stephen D.
    [J]. ANNALS OF NEUROLOGY, 2020, 88 : S154 - S155
  • [6] Efficacy of Fremanezumab in Migraine Patients Who Have Failed at Least One Prior Migraine Preventive Medication
    McAllister, Peter
    Dodick, David
    Cohen, Joshua
    Yang, Ronghua
    Yeung, Paul
    Campos, Verena Ramirez
    [J]. NEUROLOGY, 2019, 92 (15)
  • [7] Efficacy of fremanezumab in migraine patients who have failed at least one prior migraine preventive medication
    McAllister, Peter
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Yeung, Paul P.
    Ramirez Campos, Verena
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [8] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Chronic Migraine Who Have Failed At least One Prior Preventive Migraine Medication: Results of a 1-Year Study
    McAllister, P.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 119 - 119
  • [9] Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with chronic migraine who have failed at least one prior preventive migraine medication: results of a 1-year study
    McAllister, Peter
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Elms, Shawn
    [J]. CEPHALALGIA, 2019, 39 : 231 - 232
  • [10] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients with Acute Medication Overuse at Baseline: Results of a 1-Year Study
    Silberstein, S. D.
    Ashina, M.
    Cohen, J. M.
    Seminerio, M. J.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 95 - 96
12345